Study Provides Molecular Rationale For Combining Targeted Agents To Treat Breast Canc
 

A new study by Ohio State University cancer researchers provides a rational for treating breast cancer by combining two kinds of targeted agents, one that inhibits an overactive, cancer-causing pathway in cancer cells and one that reverses changes that silence genes that normally prevent cancer...

More...